Side effects of hormone replacement therapy HRT

Key takeaways

• HRT, menopause and premature ovarian insufficiency advice should be personalised after consultation.
• Benefits, side effects and risks depend on age, symptom burden, medical history, route, dose and whether progestogen is needed.
• Early menopause and premature ovarian insufficiency can affect bone, heart, fertility, mood and sexual health.
• Unexpected bleeding, severe mood symptoms, pelvic pain or symptoms before age 45 should be medically assessed.

Overview

HRT side effects can include breast tenderness, bleeding, bloating, headaches or mood changes, and should be reviewed rather than ignored.

The original article and the current thin local draft were reviewed before rewriting. This replacement keeps the same reader intent but rebuilds it with current WHM structure, British English, assessment-first language, specific safety advice and authority sources.

Oestrogen and progesterone influence temperature regulation, sleep, mood, bones, urogenital tissues, skin and the menstrual cycle. When ovarian activity changes, symptoms can affect work, relationships, sex, confidence and long-term health. HRT may help some people, but suitability is confirmed after consultation because risk and benefit are individual.

Symptoms and treatment goals

Treatment goals should be explicit: fewer flushes, better sleep, less vaginal soreness, improved urinary comfort, bone protection, safer early menopause management or support for mood and daily function. A clear goal makes review more meaningful than simply starting treatment and hoping for the best.

Symptoms can overlap with thyroid disease, pregnancy, anaemia, depression, medication effects and gynaecological conditions. Younger women, people with surgical menopause or those with cancer history need careful review rather than generic advice.

HRT and non-hormonal options

HRT can be given as tablets, patches, gels, sprays or local vaginal preparations. People with a womb usually need progestogen as well as oestrogen to protect the womb lining. Local vaginal treatment may be more appropriate when symptoms are mainly dryness, soreness, urinary discomfort or painful sex.

Non-hormonal options may include lifestyle support, psychological therapies, sleep strategies and selected prescribed medicines after consultation. Herbal or supplement claims should be treated cautiously, especially where medicines, pregnancy possibility or cancer history are relevant.

Risks, side effects and review

Possible side effects include breast tenderness, bloating, bleeding, nausea, headaches or mood changes. Risks can differ by route and personal history, including clotting risk, breast cancer history, cardiovascular risk, migraine, smoking and time since menopause. The discussion should compare the person’s baseline risk with treatment-related risk.

Review should check symptom response, side effects, bleeding, blood pressure, dose, route, ongoing need and whether new contraindications have appeared. Unscheduled bleeding on HRT should be assessed according to clinical guidance, particularly if it is heavy, persistent or occurs after a stable pattern.

Premature ovarian insufficiency

Premature ovarian insufficiency can involve fluctuating ovarian activity, so symptoms and periods may be irregular rather than absent forever. It can affect fertility plans and emotional wellbeing, and some people need specialist advice about contraception, fertility treatment or pregnancy planning.

Long-term care should cover bone density risk, cardiovascular health, sexual comfort, mood, sleep and follow-up. A diagnosis can be upsetting; support should acknowledge grief, uncertainty and the practical impact on relationships and future plans.

When to seek medical advice

Seek medical advice for menopause-like symptoms before 45, periods stopping before 45, bleeding after menopause, heavy or persistent unscheduled bleeding, pelvic pain, severe mood symptoms, breast symptoms or uncertainty about pregnancy. Use NHS 111 for urgent advice or call 999 in a life-threatening emergency.

Reader checklist

A useful clinical review should define the main problem, how long it has been present, what makes it better or worse, which treatments have already been tried, and what outcome would matter most to the patient. This prevents the consultation from becoming a generic conversation and helps the clinician decide whether examination, testing, referral, self-care or urgent action is needed.

Readers should also write down red flags before an appointment, because worrying symptoms are easy to minimise when embarrassed or rushed. New bleeding, severe pain, fever, fainting, pregnancy concerns, unexplained weight loss, new lumps, safeguarding worries or symptoms after assault should be mentioned clearly and early so the clinician can prioritise safety.

The biological reason symptoms happen is often as important as the symptom name. Hormones, immune activity, infection, tissue support, nerve sensitivity, blood supply, inflammation and cell changes can all affect women’s health symptoms. Understanding the likely mechanism helps explain why one person needs reassurance and self-care, while another needs swabs, blood tests, imaging, biopsy, specialist referral or urgent treatment.

Follow-up should be part of the plan whenever symptoms are persistent, recurrent, severe or linked with a long-term condition. The reader should know what improvement would look like, how long treatment should take to work, which side effects are acceptable, which symptoms mean treatment is failing, and who to contact if the plan does not help. Without that review point, even sensible first-line advice can become unsafe.

It is also worth checking medicines, allergies, pregnancy possibility, breastfeeding, menopause status, immune suppression, diabetes, cancer history, previous pelvic surgery and past trauma where relevant. These details can change which tests are appropriate and which treatments are safe. A personalised plan is more useful than a generic list of remedies because the same symptom can have several different causes.

If the topic affects sex, fertility, continence, bleeding, cancer worry or intimate symptoms, emotional impact should be acknowledged. Anxiety, embarrassment, relationship strain and avoidance of sex or exercise can be part of the clinical picture. Compassionate care does not mean overpromising results; it means giving accurate information, clear options and a route back for review.

Readers should be cautious with online advice that offers a single cause or a quick fix for intimate or reproductive symptoms. A symptom such as pain, bleeding, discharge, dryness, fertility difficulty or fatigue may need a different approach depending on age, cycle timing, infection risk, menopause status, medical history and examination findings. The safest advice is specific about uncertainty and clear about when professional assessment is needed.

The article should also help a reader prepare for shared decision-making. Useful questions include what diagnosis is most likely, what else has been ruled out, what tests are needed, what treatment is being offered, what benefits are realistic, what side effects or risks matter, what alternatives exist, and when to come back. These questions turn passive reassurance into a safer, more practical care plan.

Where specialist referral is suggested, it does not mean the outcome is necessarily serious. Referral can be needed for confirmation, complex symptoms, failed first-line care, cancer exclusion, fertility planning, surgery discussion, persistent infection, or symptoms affecting quality of life. Explaining the reason for referral reduces fear and helps the reader understand why waiting silently is not the best option.

For HRT and premature ovarian insufficiency, the review should include age, date of last period, contraception needs, migraine history, blood pressure, smoking, clotting history, breast history, womb history, family history and whether symptoms are mainly whole-body or vaginal and urinary. These details can change the safest route, dose and whether progestogen is needed.

The plan should include follow-up. Starting HRT, changing dose, stopping treatment or managing side effects should not be left vague. A review can check bleeding patterns, symptom response, side effects, risk changes, bone-health needs, mood, sexual comfort and whether a specialist referral is appropriate.

People with premature ovarian insufficiency may need more than symptom control. Fertility wishes, contraception if pregnancy is not wanted, bone density, cardiovascular risk, psychological support and the effect on relationships or identity should be discussed. A short appointment may not cover everything, so asking for staged follow-up is reasonable.

Sources

• NHS, Hormone replacement therapy: https://www.nhs.uk/conditions/hormone-replacement-therapy-hrt/
  Relevance: Supports HRT types, benefits, side effects, risks and review in UK patient language.
• NHS, Menopause: https://www.nhs.uk/conditions/menopause/
  Relevance: Explains menopause symptoms, diagnosis and treatment options.
• NICE NG23, Menopause recommendations: https://www.nice.org.uk/guidance/ng23/chapter/Recommendations
  Relevance: Provides UK clinical recommendations on menopause diagnosis, HRT, non-hormonal options and review.
• NHS, Early menopause: https://www.nhs.uk/conditions/early-menopause/
  Relevance: Supports early menopause and premature ovarian insufficiency assessment and treatment considerations.
• Mayo Clinic, Primary ovarian insufficiency: mayoclinic.org guidance page link unavailable during validation (mayoclinic.org guidance page, link unavailable during validation)
  Relevance: Used as a condition-page benchmark for POI symptoms, causes, diagnosis and management depth.

Disclaimer

Educational only. Results vary. Not a cure.